Mutant mitochondrial DNA with large-scale deletions (A-mtDNA) has been frequently observed in patients with chronic progressive external ophthalmoplegia (CPEO), a subgroup of the mitochondrial encephalomyopathies. To excdude involvement of the nuclear genome in expiression of the mitochondrial dysf~1nction characteristic of CPEO, we introduced the mtDNA of a CPEO patient into' clonal mtDNA-less HeLa cells and isolated cybrid clones. Quaqtitation' of A-mtDNA in the cybrids revealed that A-mtDNA was selectively propagated with higher levels of A-mtDNA correlating with slower cellular growth rate. In these cybrid clones, translational complementation of the missing tRNAs occurred only when A-mtDNA was <60% of the total mtDNA, whereas accumulation of A-mttDNA to >60% resulted in progressive inhibition of overall mitochondrial translation as well as reduction of cytochrome c oxidase a#ctivit'tthroughout the organelle population. Because these'cybrids shared the same nuclear background as HeLa cells, these results suggest that large-scale deletion mutations of mtDNA alone are sufficient for the mitochondrial dysfunction characteristic of CFEO. Recently, heteroplasmy of wt-mtDNA and mutant mtDNA with a point mutation in the mitochondrial tRNALYS and tRNAUbUR genes was shown to be closely associated with MERRF (9) and MELAS (10-12), respectively. However, there is as yet no convincing-evidence to explain how mutant mtDNA induces mitochondrial dysfunction, or whether the mutations of mtDNA alone are sufficient to cause mitochondrial dysfunction in these diseases.
cdude involvement of the nuclear genome in expiression of the mitochondrial dysf~1nction characteristic of CPEO, we introduced the mtDNA of a CPEO patient into' clonal mtDNA-less HeLa cells and isolated cybrid clones. Quaqtitation' of A-mtDNA in the cybrids revealed that A-mtDNA was selectively propagated with higher levels of A-mtDNA correlating with slower cellular growth rate. In these cybrid clones, translational complementation of the missing tRNAs occurred only when A-mtDNA was <60% of the total mtDNA, whereas accumulation of A-mttDNA to >60% resulted in progressive inhibition of overall mitochondrial translation as well as reduction of cytochrome c oxidase a#ctivit'tthroughout the organelle population. Because these'cybrids shared the same nuclear background as HeLa cells, these results suggest that large-scale deletion mutations of mtDNA alone are sufficient for the mitochondrial dysfunction characteristic of CFEO.
Molecular evidence that mitochondrial DNA (mtDNA) mutations may-beassociated with human diseases was first reported by Holt et al. (1) , who observed heteroplasmy of wild-type mtDNA (wt-mtDNA) and mutant mtDNA with a large-scale deletion (A-mtDNA) in the skeletal muscles of patients with mitochondrial encephalomyopathies. These diseases are usually defined'by morphological and functional abnormalities of muscle mitochondria, and they have been divided into three distinct subgroups (2) : (i) chronic progressive external ophthalmoplegia (CPEO) including Kearns- Sayre syndrome, (ii) myoclonus -,epilepsy associated with ragged red fibers (MERRF), and (iii) mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Heteroplasmy of wt-and A-mtDNA has been frequently observed in CPEO includipg Kearns-Sayre syndrome (3, 4) and in Pearson syndrome (4, 5) . Moreover, histochemical studies have suggested that deletion mutations of mtDNA are related to focal cytochrome c oxidase (COX) deficiency in the skeletal' muscles of CPEO patients (6) (7) (8) .
Recently, heteroplasmy of wt-mtDNA and mutant mtDNA with a point mutation in the mitochondrial tRNALYS and tRNAUbUR genes was shown to be closely associated with MERRF (9) and MELAS (10) (11) (12) , respectively. However, there is as yet no convincing-evidence to explain how mutant mtDNA induces mitochondrial dysfunction, or whether the mutations of mtDNA alone are sufficient to cause mitochondrial dysfunction in these diseases.
In the present study, by cytoplasmically transmitting CPEO-derived mtDNA to clonal mtDNA-less HeLa EB8 cells, we found that A-mtDNA had a clear propagational advantage over wt-mtDNA and that its consequent accumulation to over 60o of the'total mtDNA resulted in a progressive inhibition of overall mitochondrial translation as well as a reduction of COX activity. As-the mtDNA-recipient EB8 cells were clonal and thus shared the same nuclear background, we conclude that large-scale deletion mutations of mtDNA induced the mitochondrial dysfunction characteristic of the disease directly without the help of any defects in the nuclear genome.
MATERIALS AND METHODS
Cell Culture. mtDNA-less HeLa EB8 cells were isolated by the procedure of King and Attardi (13) through long-term treatment of HeLa cells with ethidium bromide (14) . Primary skin fibroblasts were obtained from a 14- nine. In this mtDNA transfer system, however, as no method for genetic selection to remove parental EB8 cells was available, the colonies that grew in the medium with 6-thioguanine were either cybrids or the parental EB8 cells. However, growth of cells with mtDNA (cybrids) is expected to be slightly better than that of mtDNA-less cells, so for preferential selection of cybrids we picked up 127 colonies growing relatively fast. Of 127 clones, 6 clones had mtDNA. mtDNA Analysis. The total DNA (2-5 jig) extracted from 2 x 105 cells was digested with the single-cut restriction enzyme Pvu II. The fragments separated by 0.8% agarose gel electrophoresis were then transferred to nitrocellulose membranes and hybridized with [a-32P]dCTP-labeled HeLa mtDNA. The membranes were washed and exposed to x-ray film (Fuji-RX, Fuji Film, Tokyo) for 1 hr at -80'C. To quantitate the A-mtDNA contents in the cybrid clones, the membranes were exposed to imaging plates (Fuji Film) for 5 min, and the radioactivity of each fragment was measured using a bioimaging analyzer, Fujix BAS 2000 (Fuji Film). Of the six cybrid clones containing mtDNA, three had only wt-mtDNA, while the other three also contained various proportions of A-mtDNA (Fig. 1) . The restriction patterns of Hha I, which can distinguish HeLa mtDNA from other human mtDNA (20, 21) , showed that both wt-and A-mtDNA were exclusively derived from the mtDNA-donor fibroblasts (data not shown).
Propagation Profiles of A-mtDNA in Cybrids. Using the cybrid clones, we first examined the propagation profiles of A-mtDNA in dividing cells cultivated in glucose-rich medium, in which even EB8 cells were able to grow. Quantitative analysis of the change in mtDNA composition with time showed that A-mtDNA has a clear propagational advantage over wt-mtDNA, rapidly and reproducibly accumulating to a predominant content of 75-85% in all three clones within 10 weeks after the fusion (Fig. 2A) . 
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The ratio of the total radioactivity contained in Pvu II fragments of clone 5, with 89% A-mtDNA, to that of clone 1, without A-mtDNA (Fig. 1A) , was 1.12. Thus, the increase in A-mtDNA content corresponded with the decrease in wtmtDNA content, the total amount of mtDNA per cell remaining essentially unchanged. This is different from the case in diseased skeletal muscle fiber (ragged red fiber) segments, where the total amount of mtDNA was several times higher than that in normal muscle fiber segments (7) .
The accumulation of A-mtDNA was followed by a stable equilibrium state with A-mtDNA content of 75-85% ( To disclose this threshold, we isolated six subclones 19 weeks after clonal isolation of clone 5. The variation in A-mtDNA contents observed in the subclones was biased to higher contents of A-mtDNA ( Fig. 2A ) and the subclones with higher contents grew poorly (Fig. 2B) . Such A-mtDNAbiased partitioning of mtDNA could be due to its propagational advantage. Thus, it appears that A-mtDNA can accumulate up to a threshold, beyond which a further increase in A-mtDNA is selected against for reasons most likely associated with cell growth.
The threshold decreased to 50% in medium without glucose, which was lethal to cells with >72% A-mtDNA as well as to EB8 cells (Fig. 2) . This implies that the thresholds in dividing tissues in vivo may also vary depending on environmental factors, such as the sorts of energy sources and their concentrations. The threshold in the in vivo fibroblasts would be below 34-53% ( Fig. 2A) , if one assumes that A-mtDNA also accumulated during the 23 passages of the primary culture before fusion. This would enable cells without A-mtDNA to develop even when random partitioning of mtDNA was biased to A-mtDNA. As cells without A-mtDNA grew faster (Fig. 2B) , as suggested by Moraes et al. (22) , dividing tissues with low thresholds of A-mtDNA would be able to eliminate A-mtDNA. In contrast, dividing tissues with high thresholds can accumulate A-mtDNA as skeletal muscle does in CPEO. Thus, in the human disease state, diversity in both of the cellular microenvironment and the cellular requirement of energy might permit different thresholds with subsequent diverse effects on cellular physiology.
The propagation profiles of A-mtDNA in dividing cells (Fig. 2) explain well the "progressive nature" of the disease, and this could be a good model to account for the propagation of A-mtDNA in the Pearson syndrome, where 80-90%o A-mtDNA has been observed in bone marrow cells and lymphocytes (23) .
Effects of A-mtDNA Proportions on Transcription, Translation, and COX Activity. We analyzed the influence of mtDNA genotypes (the ratio of A-mtDNA to wt-mtDNA) on mitochondrial transcription and translation and also studied their effect on the phenotypic expressions characteristic of the disease by using cybrids with various contents of A-mtDNA.
Northern blot analysis (Fig. 3) showed that as the contents of A-mtDNA increased, the contents of the transcripts of ND4 and ATPase6/8 genes missing in A-mtDNA decreased correspondingly. The transcripts of the putative "fusion genes" of length 1.3 kbp (see Fig. 1B ) increased proportionally with the increase of A-mtDNA. All the mRNAs and rRNAs tested were transcribed almost proportionally to the contents of their corresponding genes (Fig. 3B) . This is consistent with the previous observations that A-mtDNA was transcriptionally active (6, 7, 24 Chomyn et al. (25) , and these 12 polypeptides could thus be assigned to mtDNA genes. One additional polypeptide, which corresponded well to the predicted fusion protein B (see Fig. 1B ), was observed in cells with 55% and 61% A-mtDNA (Fig. 4A) . Moreover, the significant increase in radioactivity of the ATPase8 band exclusively in cells with 55% A-mtDNA suggested that this increase was due to comigration of the predicted fusion protein A with the ATPase polypeptide. Thus, these polypeptides could be the fusion proteins, although their amino acid sequences were not determined. Quantitative estimation of mtDNA translation products and COX activity showed that both overall translation and COX activity decreased, particularly when >60% A-mtDNA A.. . m . l p m . mitochondia insW-cybrid clone 5 were COX-negative, whe 9 had accumulated ( Fig. 411 and C Proc. Natl. Acad. Sci. USA 88 (1991) amphenicol-sensitive mtDNA (26) . However, such translational complementation and competition could not occur if wt-and A-mtDNA or chloramphenicol-sensitive and chloramphenicol-resistant mtDNA were segregated in different mitochondria. COX electron micrographs (Fig. 5) clearly showed that individual mitochondria in cells with 75% A-mtDNA had lost COX activity uniformly and were considerably swollen, with disorganized inner membranes. In addition, the COX activity was recovered in most of mitochondria in the cells with <60% A-mtDNA (the details will be published elsewhere). This provides direct evidence for the coexistence of A-and wt-mtDNA within the same organelles, allowing translational complementation and competition. Accordingly, in cultured cells and dividing tissues where levels of A-mtDNA are >60%o, mitochondrial translation may become limiting, and the translation phase may be shifted from complementation to competition, resulting in progressive inhibition of overall mitochondrial translation as well as reduction of COX activity. In this study, we excluded the influence of any nuclear gene on the mitochondrial dysfunction by introducing the mtDNA of a CPEO patient into clonal EB8 cells. Thus, the cybrids shared the same nuclear background and consequently the results showed that large-scale deletion mutations of mtDNA alone were sufficient for the observed respiration defects. A possibility cannot be excluded completely that the A-mtDNA possesses one or more additional mutations and that these also contribute to the observed changes. However, even if this is the case, it is concluded that accumulation of A-mtDNA induces the mitochondrial dysfunction characteristic of CPEO.
Recently, some point mutations of mitochondrial tRNA genes have been shown to be closely associated with mitochondrial encephalomyopathies other than CPEO (9) (10) (11) (12) . Our mtDNA transmission system would also be applicable for studying the roles of these tRNA mutations. More recently, Chomyn et al. (27) have reported cotransfer of a MERRF-associated tRNALYS mutation and respiration defects into mtDNA-less human cells.
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